ScholarIQanswers from OpenAlex & ORCID
Dean J. Kereiakes
ResearcherPublications, citations & collaboration network
Dean J. Kereiakes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Dean J. Kereiakes have?
ScholarIQindexed works
Dean J. Kereiakes has 756 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Dean J. Kereiakes have?
ScholarIQcitation count
Dean J. Kereiakes has 55,630 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Dean J. Kereiakes?
ScholarIQh-index
Dean J. Kereiakes has an h-index of 109 in OpenAlex.
What is the i10-index of Dean J. Kereiakes?
ScholarIQi10-index
Dean J. Kereiakes has an i10-index of 373 in OpenAlex.
What is the ORCID of Dean J. Kereiakes?
ScholarIQorcid
The ORCID for Dean J. Kereiakes is on the source record.
What is the OpenAlex record for Dean J. Kereiakes?
ScholarIQopenalex
The OpenAlex for Dean J. Kereiakes is on the source record.
What are the most-cited papers on Dean J. Kereiakes?
ScholarIQmost cited works
ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations
Eugene Braunwald, Elliott M. Antman, John W. Beasley, Robert M. Califf, Melvin D. Cheitlin, Judith S. Hochman, Robert H. Jones, Dean J. Kereiakes, Joel Kupersmith, Thomas N. Levin, Carl J. Pepine, John W. Schaeffer, Earl E. Smith, David E. Steward, Pierre Théroux, Raymond J. Gibbons, Joseph S. Alpert, Kim A. Eagle, David P. Faxon, Valentı́n Fuster, Timothy J. Gardner, Gabriel Gregoratos, Richard O. Russell, Sidney C. Smith
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma, Peter J. Fitzgerald, David R. Holmes, Charles O’Shaughnessy, Ronald Caputo, Dean J. Kereiakes, David O. Williams, Paul S. Teirstein, Judith Jaeger, Richard E. Kuntz
Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary Intervention
A. Michael Lincoff, John A. Bittl, Robert A. Harrington, Frederick Feit, Neal S. Kleiman, J. Daniel Jackman, Ian J. Sarembock, David J. Cohen, Douglas Spriggs, Ramin Ebrahimi, Gadi Keren, Jeffrey Carr, Eric A. Cohen, Amadeo Betriu, Walter Desmet, Dean J. Kereiakes, Wolfgang Rutsch, Robert G. Wilcox, Pim J. de Feyter, Alec Vahanian, Eric J. Topol, for the REPLACE-2 Investigators
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
Vinod H. Thourani, Susheel Kodali, Raj Makkar, Howard C. Herrmann, Mathew Williams, Vasilis Babaliaros, Richard W. Smalling, Scott Lim, S. Chris Malaisrie, Samir Kapadia, Wilson Y. Szeto, Kevin L. Greason, Dean J. Kereiakes, Gorav Ailawadi, Brian Whisenant, Chandan Devireddy, Jonathon Leipsic, Rebecca T. Hahn, Philippe Pîbarot, Neil J. Weissman, Wael A. Jaber, David J. Cohen, Rakesh M. Suri, E. Murat Tuzcu, Lars G. Svensson, John G. Webb, Jeffrey W. Moses, Michael J. Mack, D. Craig Miller, Craig R. Smith, Maria Alu, Rupa Parvataneni, Ralph B. D’Agostino, Martin B. Leon
Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy
Theodore Chow, Dean J. Kereiakes, Cheryl Bartone, Terri Booth, Edward J. Schloss, Theodore Waller, Eugene Chung, Santosh Menon, Brahmajee K. Nallamothu, Paul S. Chan